The latest news and breakthrough developments from the field of cancer research. We bring you the latest updates from organisations looking into diagnosing and treating all types of cancers using the latest scientific advancements and what is being done to improve patient care.
Cancer cells are masters of disguise, evading immune destruction through cunning mechanisms. Groundbreaking research reveals a novel tactic: mitochondrial transfer. Cancer cells cripple immune cells by donating their damaged mitochondria, hindering the immune response and fostering tumour growth.
The UK government is investing £82.6 million in groundbreaking research to harness the power of artificial intelligence (AI) to transform cancer care and accelerate drug discovery.
Lorna Rothery interviewed Dr John Glod from the National Cancer Institute, which is part of the National Institutes of Health, about the main challenges in childhood cancer treatment and the advancements in care.
Tarlatamaba, a new treatment for adult patients with small cell lung cancer (SCLC), has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA).
Infections are the second leading cause of death in cancer patients, after the cancer itself; Zisis Kozlakidis and Shalini Jayasekar Zurn discuss the challenges surrounding the interplay between cancer and antimicrobial resistance (AMR).
The Amplitude Consortium is thrilled to announce its final online workshop, the Amplitude Project Showcase, where the latest advancements in multi-modal imaging for bladder cancer diagnosis and therapy monitoring will be unveiled.
The NHS is looking for volunteers as part of the three cancer projects that have been selected as part of the NHS DigiTrials initiative. Almost 150,000 volunteers will take part in these trials to help transform cancer treatment.
Gareth Jenkins, a partner at Changeology Group Ltd, discusses the potential of detailed analysis to enhance the efficiency of cancer care within the NHS.
